Nitazenes, less detectable and sometimes stronger than fentanyl, have been detected across more than a dozen states.

The report states that Nitazenes, highly potent synthetic opioids developed in the 1950s, have been emerging in overdose ...

Despite recent declines, the U.S. Food and Drug Administration (FDA) says opioids remain commonly prescribed to about 1 in 5 ...

Nitazenes, a powerful and largely hidden class of synthetic opioids, are quickly becoming a deadly factor in the overdose ...

A retrospective study examines opioid prescription trends from 2017 to 2023, identifying a significant overall decrease and shifts related to the COVID-19 pandemic.

Nitazenes—a class of highly potent synthetic opioids—are rapidly emerging as a major contributor to the overdose crisis, according to a Pain Medicine review published today by authors from Vanderbilt ...

Pharmacies in Black and Latino neighborhoods are less likely to dispense buprenorphine — one of the main treatments for ...

In this week’s edition of InnovationRx, we look at risks of new vaccine restrictions, virtual clinical trials at the Mayo ...

OPINION - California has already shown the courage to lead on the opioid crisis. Now it must finish the job. By making ...

As we continue to observe National Recovery Month, Homeland Security Today contributor Robert Patterson – former Acting ...

The state's opioid settlement spending has not been without missteps, which were heavily criticized by Attorney General ...